Concert to Benefit UC Medical Student Scholarship Fund
The event, which features musical performances from
The fund, named after assistant dean IvaDean Lair, was created by the outgoing medical class of 2003 as a way to honor Lairs 40-plus years of service to the college and provide relief to students burdened by the escalating costs of medical school tuition.
Daniel Burr, PhD, assistant dean for student financial planning at the college, says that more than half of the 2007 class graduated with over $150,000 in outstanding educational debt.
Medical school is not only expensive, but its also very challenging, says Burr. Our goal is to train and graduate leaders in the medical field. By providing opportunities for financial support, we are allowing students to focus even more on their studies and not on how they will manage financially.
Since 2004, the IvaDean Medical Student Scholarship Fundset up as a permanent endowmenthas generated $81,000 to fund scholarships. Students are awarded scholarships based solely on financial need. Eleven students currently benefit from the fund.
The benefit concert is open to the public. Tickets are $5 for students and children and $20 for adults, and can be purchased at the door. All event proceeds will directly support the IvaDean Medical Student Scholarship Fund. For more information, call (513) 558-5577 or e-mail benefit.concert@gmail.com.
2006 IvaDean Benefit Concert.
The IvaDean Scholarship Benefit Concert is organized and produced by students for the benefit of fellow students.
Medical student Tom Stamatis belts out a tune at the third annual IvaDean Scholarship Benefit Concert.
2006 IvaDean Benefit Concert.
2006 IvaDean Benefit Concert.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.